Aier Eye Hospital invests $200m in wealth management for capital optimization

Aier Eye Hospital Group Co., Ltd. announced cash management using idle funds, following a resolution passed at its Sixth Board of Directors' Thirty-Second Meeting on March 24, 2025. The company is authorized to invest up to 1.5 billion yuan in wealth management products that are highly secure, liquid, and low-risk, for a period of 12 months from the resolution date, with funds capable of being rolled over. This initiative aims to improve capital utilization and generate investment returns without compromising daily operational cash flow or financial security.

The first announced investment under this scheme is for 200 million yuan in the "Harvest Bird All-Weather Investment Advisory Portfolio (Public Fund Investment Advisory Portfolio)." This product is categorized as medium-low risk with an earnings benchmark of the People's Bank of China 1-year fixed deposit rate +2%. The interest accrual period for this particular investment begins on December 24, 2025, with funds available for redemption at any time.

This recent transaction is part of a broader strategy, with the company disclosing several other wealth management product purchases using idle funds within the past twelve months. These include investments with various financial institutions, such as China Minsheng Bank, China Everbright Bank, and Ping An Bank, in products offering varying yields and durations. All these investments are categorized for enhancing capital efficiency and shareholder returns.